Other sites of metastasis included the bladder (n = 5), adrenal gland (n = 3), renal (n = 2), and uterus (n = 1). Fig 1. (A) DFS in the intent-to-treat population. (B) DFS in patients with different ...
FDA labeling now recommends DPYD variant testing before initiating capecitabine or 5-FU, except when immediate treatment is clinically necessary. Complete DPD deficiency markedly impairs 5-FU ...